| Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement | 06/26 08:30 | accesswire.com |
| Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders | 06/21 16:15 | accesswire.com |
| Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024 | 06/12 08:30 | accesswire.com |
| Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 06/07 16:15 | accesswire.com |
| US Stocks Mixed; Li Auto Shares Plummet After Q1 Results | 05/20 09:57 | https://www.benzinga.com |
| Why Is Jaguar Health (JAGX) Stock Down 40% Today? | 05/20 09:37 | investorplace.com |
| Jaguar Health, Inc. Announces Reverse Stock Split | 05/17 16:15 | accesswire.com |
| Jaguar Health Reports First Quarter 2024 Financial Results | 05/14 08:00 | accesswire.com |
| REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, May 14th at 8:30 AM Eastern Regarding Q1 2024 Financials & Corporate Updates | 05/13 12:35 | accesswire.com |
| Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications Microvillus Inclusion Disease (MVID) and Short Bowel Syndrome (SBS) in Europe | 05/09 10:35 | accesswire.com |